Late-occurring toxicity induced by an immune checkpoint blockade in adjuvant treatment of a stage III melanoma patient

被引：24
|
作者：
Mandala, Mario [1 ]
Merelli, Barbara [1 ]
Indriolo, Amedeo [2 ]
Tondini, Carlo [1 ]
机构：
[1] Papa Giovanni XXIII Hosp, Dept Hematol & Oncol, Med Oncol Unit, Bergamo, Italy
[2] Papa Giovanni XXIII Hosp, Gastroenterol Unit, Bergamo, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 95卷
关键词：
ANTI-PD-1; THERAPY; IPILIMUMAB;
D O I：
10.1016/j.ejca.2018.02.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：130 / 132
页数：3
相关论文
共 50 条
  • [41] Targeted Therapy for the Adjuvant Treatment of Stage III BRAF-Mutated Melanoma
    Long, Georgina
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (01) : 25 - 27
  • [42] Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry
    Ozkan, A.
    Kapiteijn, E.
    van den Bos, F.
    Aarts, M. J. B.
    van den Berkmortel, F. W. P. J.
    Blank, C. U.
    Bloem, M.
    Blokx, W. A. M.
    Boers-Sonderen, M. J.
    Bonenkamp, J. J.
    van den Eertwegh, A. J. M.
    de Groot, J. W. B.
    Haanen, J. B.
    Holtslag, C. E.
    Hospers, G. A. P.
    Piersma, D.
    van Rijn, R. S.
    Boer, A. M. Stevense-den
    Suijkerbuijk, K. P. M.
    van der Veldt, A. A. M.
    Vreugdenhil, G.
    Wouters, M. W. J. M.
    Portielje, J. E. A.
    de Glas, N. A.
    EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [43] Thymic hyperplasia following treatment with checkpoint inhibitors in a patient with stage IV melanoma
    Foo, Tiffany
    Mencel, Justin
    Karanth, Narayan
    Pokorny, Adrian
    Charakidis, Michail
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 182 - 182
  • [44] Immune-mediated eosinophilic Fasciitis under Immune Checkpoint Blockade and the Intolerability of targeted Therapy in Patient with metastatic Melanoma
    Meisterfeld, S.
    Garzarolli, M.
    Beissert, S.
    Meier, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 54 - 54
  • [45] Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient
    Boutros, Andrea
    Schiavi, Chiara
    Cecchi, Federica
    Spagnolo, Francesco
    Guadagno, Antonio
    Tanda, Enrica Teresa
    Giusti, Francesca
    Murdaca, Giuseppe
    Queirolo, Paola
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [46] Patient-reported outcomes of patients treated with (neo)adjuvant immune checkpoint combination therapy in high-risk stage III macroscopic melanoma: A matched cohort study.
    Boekhout, Annelies H.
    Jozwiak, Katarzyna
    Rozeman, Elisa A.
    Janssen, Silvie H. M.
    van de Poll-Franse, Lonneke V.
    Blank, Christian U.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] The peripheral blood TCR repertoire to facilitate patient stratification for immune checkpoint blockade inhibition in metastatic melanoma
    Goldinger, Simone M.
    Courtier, Anais
    Jaberg-Bentele, Nicoletta F.
    Schindler, Sabrina
    Manuel, Manuarii
    Plantier, Nadia
    Treillard, Bertrand
    Noel, Marlene
    Thi Dan Linh Nguyen-Kim
    Raaijmakers, Marieke Ineke Geertje
    Kvistborg, Pia
    Haanen, John B. A. G.
    Dummer, Reinhard
    Levesque, Mitchell
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Immune biomarkers for recurrence in stage II and III melanoma to guide patient stratification
    Espinoza, Gerardo A.
    Zhang, Chenxin
    Moon, Jee-Young
    Kenchappa, Divya B.
    Abbruzzese, Matteo
    Bioh, Lydia
    Bracero, Yadriel M.
    Sultana, Sharmin
    Singh, Ajay
    Aung, Thazin
    Krolewski, John J.
    Gartrell, Robyn D.
    Geskin, Larisa J.
    Leung, Lawrence W.
    Ferringer, Tammie
    Chang, Rui
    Horst, Basil
    Nastiuk, Kent
    Saenger, Yvonne M.
    CANCER RESEARCH, 2024, 84 (06)
  • [49] TREATMENT EXPERIENCE AND PYREXIA MANAGEMENT IN A PATIENT WITH STAGE III MELANOMA RECEIVING ADJUVANT BRAF/MEK-TARGETED THERAPY
    King, Jeanelle
    McGettigan, Suzanne
    Kottschade, Lisa
    Rubin, Krista
    Madden, Kathleen
    Seery, Virginia
    ONCOLOGY NURSING FORUM, 2021, 48 (02)
  • [50] Blood Immune Cell Biomarkers in Patient With Lung Cancer Undergoing Treatment With Checkpoint Blockade
    Moeller, Miriam
    Turzer, Steffi
    Schuette, Wolfgang
    Seliger, Barbara
    Riemann, Dagmar
    JOURNAL OF IMMUNOTHERAPY, 2020, 43 (02) : 57 - 66
12345